Ridge splitting
ProcedurePatients with narrow alveolar ridge will undergo ridge splitting procedure using chisel to allow implant placement.
NCT Number: NCT07534787
This study aims to evaluate the tissue biotype and bone density around dental implants in patients with narrow alveolar ridge. Ridge splitting with simultaneous implant placement covered with concentrated growth factor (CGF) membranes will be performed. Clinical and radiographic evaluation will be done using periodontal probe and CBCT. Pain will also be assessed using visual analogue scale (VAS) during follow-up period.
Trial opening soon.
Get Notified18 year–60 year
All sexes
Interventional
Not applicable
Cairo university, Cairo, Egypt
This study is a case series conducted at the outpatient clinic of the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University. It aims to evaluate the tissue biotype and bone density around dental implants in adult patients with narrow alveolar ridge.
Alveolar ridge resorption and soft tissue shrinkage after tooth extraction represent a major problem affecting both aesthetics and function. Therefore, preserving alveolar bone and improving soft tissue conditions are essential for successful implant placement. The use of concentrated growth factor (CGF) membranes combined with ridge splitting and simultaneous implant placement may enhance healing, reduce postoperative pain, and improve tissue biotype and bone density.
All patients will undergo clinical and radiographic assessment before the procedure. Preoperative CBCT will be used for surgical planning. Tissue thickness will be measured using a periodontal probe. During surgery, ridge splitting will be performed followed by implant placement, and CGF membranes will be applied over the grafted area. Autologous bone chips will be used for augmentation.
Postoperative evaluation will include assessment of tissue biotype, bone density using CBCT, and pain using visual analogue scale (VAS). Follow-up will be carried out immediately after surgery and up to 4 months postoperatively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Patients with narrow alveolar ridge indicated for implant placement Age between 20 and 50 years Good general health Patients with adequate oral hygiene
Exclusion criteria
Patients with narrow alveolar ridge will undergo ridge splitting procedure using chisel to allow implant placement.
Intervention Description:
Dental implants will be inserted simultaneously after ridge splitting in the prepared alveolar ridge.
CGF membranes will be prepared from patient venous blood and placed over the grafted area to enhance healing and tissue regeneration.
Time frame: 1st day and 3rd day postoperative
Pain will be assessed using Visual Analogue Scale (VAS) ranging from 0 to 10.
Time frame: Immediately postoperative and after 4 months
Tissue biotype will be assessed using a periodontal probe and measured in millimeters.
Time frame: Immediately postoperative and after 4 months
Bone density will be evaluated using CBCT and measured in Hounsfield units (HU).
Contact information is provided by the study sponsor or research team.
Cairo University
Other
Clinical and Radiographic Evaluation of Ridge Splitting With Simultaneous Implant Placement Covered With Concentrated Growth Factor Membranes in Narrow Alveolar Ridge (Case Series).
Acronym: CGF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737132
Breast Cancer, Breast Diseases
View Trial DetailsNCT07729488
Neurologic Manifestations, Pain
Diyarbakır, Outside of the US, Turkey (Türkiye)
View Trial DetailsNCT07726550
Agnosia, Nervous System Diseases
Tekirdağ, Turkey (Türkiye)
View Trial DetailsNCT07716943
Cardiac Surgery, Cardiopulmonary Bypass
Istanbul, Turkey (Türkiye)
View Trial Details